We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Yourgene Health Plc | LSE:YGEN | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.515 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 0.515 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 11/9/2023 | 06:00 | UKREG | Yourgene Health PLC De-listing and cancellation of trading of Shares |
| 08/9/2023 | 11:00 | UKREG | Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Yourgene Health plc |
| 08/9/2023 | 10:58 | ALNC |  Novacyt completes buy of molecular diagnostics firm Yourgene Health |
| 08/9/2023 | 10:23 | UKREG | Yourgene Health PLC Scheme of Arrangement becomes Effective |
| 08/9/2023 | 08:54 | UKREG | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
| 08/9/2023 | 06:30 | UKREG | AIM Suspension - Yourgene Health Plc |
| 07/9/2023 | 19:27 | ALNC | TRADING UPDATES: Tintra receives bid approach; NCC trading in line |
| 07/9/2023 | 10:46 | UKREG | Yourgene Health PLC Court sanction of the Scheme of Arrangement |
| 07/9/2023 | 09:10 | UKREG | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
| 06/9/2023 | 09:46 | UKREG | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
Yourgene Health (YGEN) Share Charts1 Year Yourgene Health Chart |
|
1 Month Yourgene Health Chart |
Intraday Yourgene Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 18/8/2023 | 07:50 | YGEN | 3,358 |
| 20/5/2020 | 06:42 | YourGene to Infinity | 2,121 |
| 04/5/2020 | 07:06 | Partnership with Novacyt | 2 |
| 30/3/2020 | 07:20 | Yourgene Health at the UK Investor Show | 3 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 03/8/2023 13:15 by major courtenay I concede I’m being a dog in the manger by voting against. It irks me that Nova is getting out company and all its potential for peanuts.Nova share price is rising because everyone knows they’re perpetrating a massive heist. |
Posted at 03/7/2023 08:52 by major courtenay My point is that Novacyt know what they’re buying. And they believe Ygen is worth 0.52p as a minimum. I might be inclined to sell for double that. Likely to vote against this.I wouldn’t be surprised if quite a few vote against. Probably not enough to stop it, but we all know this is too low an offer. I honestly believe Ygen is worth more than this and we should hold out for more. |
Posted at 03/7/2023 08:20 by major courtenay Tempted to vote against. The point is that we now know what an independent third party knows what Ygen is worth as a minimum (depending of course, on whether lr is involved in the new entity. Looks like he’s kept on, but don’t think he was involved with Novacyt) |
Posted at 03/7/2023 06:05 by pharmaboy3 It's one of my biggest flops !My only hope is that LR has no future in the running of the company Yourgene Health PLC - Rule 2.7 Announcement #YGEN @Yourgene_Health HTTps://www.voxmarke |
Posted at 03/4/2023 18:11 by twix386 Let's get it done ffs, so that we and the share price can hopefully all move on.Dragging it out serves nobody and clearly LR isn't for falling on his sword unless he's pushed.The lack of news this last year. The funding fiasco. The vow of silence. The modest commercial news that Ranger is delivering, let alone creating a revolution.The demonstrable lack of competence.We were told about various negs on going in USA at various stages including advanced and of the biggest contract to date for Ranger and Taiwan divestment and Strategic investment both of which we seemed to pin our funding on until it became clear they would not arrive in time - hence distressed Placing -YET as if to show the mismanagement we are still waiting for any news!!The relentless disappointment is farcical! |
Posted at 11/1/2023 17:41 by catch007 Birdie12: Good luck to you in your dealings with YGEN.I lost complete faith in the BOD which imho lacks integrity and has deceived investors on its trading position hence I will not invest further in YGEN. Like many PI's I have sustained losses having bought a decent holding on the potential particularly on US ranger prospects which the BOD continually talked up. Sadly I didnt sell on the declining share price however few if any expected a disaster fund raise at nominal value. Hopefully in time the share price will respond to better trading news but is unlikely to reach previous levels given the billions of shares now available! I am not certain whether £6.8m net raise is enough to get YGEN through the coming months unless testing volumes increase hugely and cost savings are realised. Good IP, good product range ruined by a growth at all costs strategy and a CFO who has failed to exercise any financial diligence on an obvious revenue and cashflow gap! |
Posted at 05/12/2022 18:43 by twix386 Shaun Day, MD at Greatland Gold invites you all to come and see him present and take Q&A at his fourth London Town Hall of the year next Wednesday. A great opportunity to catch up 1-1 on progress. Please register here. Sh |
Posted at 22/11/2022 23:49 by catch007 Melton John: I felt 13% fall in share price was indeed a steep fall, hardly describe that as tripe. My question was posed to elicit some sensible views re the current position especially around the cash position which was not stated in recent TU.I was and remain positive around Ranger applications. The core YGEN business model is a volume orientated testing play so recent US partnerships need to deliver in H2 to generate cash. I really see little value or merit in discussing whether opening or closing prices re 2.5p or 2.6p both are irrelevant, more valuable is the future direction of travel of YGEN share price Like you I am a LTH of YGEN I may add again once more certainty is available however despite your Stockopedia data (thank you) there remains much confusion and conjecture at present as to the true prospects of the company at present. |
Posted at 08/11/2022 19:41 by ngen yap Still here Twix.Poor management of share price performance.Credible execution of business plan and strategy, with room for improvement.Let's hope the gap between the two will close.I remain confident of YGEN future and certainly consider it great value at this share price.If I had £20m, or even £10m, I would love to take control of it.But I hope someone will snap us up at a huge premium. Don't mind a cash + stock deal to stay in the ride. I like EKF actually, and can see lots of synergies. Perhaps they can :-) |
Posted at 01/11/2022 16:22 by ngen yap If I were Labcorp, I would just buy YGEN - can probably snap us up for $150m given our share price Not only can they save on future royalties to Ravgen (subject to appeal), they can switch over total NIPT customer to IONA Nx so preserving sales, improving margins and better accuracies.Additiona |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
